Literature DB >> 346006

Use of synthetic absorbable sutures for abdominal and chest wound closure. Experience with 650 consecutive cases.

D H Murray, F W Blaisdell.   

Abstract

The advent of synthetic collagen suture (polyglycolic acid and polyglacin 910) has provided a new dimension in surgical suturing. However, surgeons in general have not yet taken full advantage of the potential that this new material offers. Associated evisceration and wound dehiscence rates as well as the incidence rate of wound infection were assessed since these represent standards by which the suture material can be evaluated. In an entire series of 650 cases, there has been one case of wound dehiscence with evisceration. The incidence of infection has been less than 1%, which is comparable to previous experience with interrupted, nonabsorbable sutures. The time required for closure using the new material has been approximately one third of that associated with the use of conventional interrupted closure sutures. This implies a substantial cost reduction for the patient. As a result of this experience, the synthetic absorbable sutures seem to represent the material of choice for routine abdominal or chest wound closure.

Entities:  

Mesh:

Year:  1978        PMID: 346006     DOI: 10.1001/archsurg.1978.01370160135023

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  3 in total

1.  Le choix d'un matériel de suture.

Authors:  M Olivieri; N H Bonneau
Journal:  Can Vet J       Date:  1985-01       Impact factor: 1.008

2.  Abdominal wound closure. A randomized prospective study of 571 patients comparing continuous vs. interrupted suture techniques.

Authors:  P C Richards; C M Balch; J S Aldrete
Journal:  Ann Surg       Date:  1983-02       Impact factor: 12.969

3.  A Prospective Randomized Study Comparing Non-absorbable Polypropylene (Prolene®) and Delayed Absorbable Polyglactin 910 (Vicryl®) Suture Material in Mass Closure of Vertical Laparotomy Wounds.

Authors:  Sharad Pandey; Mohinder Singh; Kuldip Singh; Sartaj Sandhu
Journal:  Indian J Surg       Date:  2012-04-19       Impact factor: 0.656

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.